Raia Drogasil (OTCMKTS:RADLY) Stock Price Up 14.1% – Time to Buy?

Shares of Raia Drogasil S.A. (OTCMKTS:RADLY) shot up 14.1% during trading on Tuesday. The stock traded as high as $4.3370 and last traded at $4.3350. 3,693 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 86,805 shares. The stock had previously closed at $3.80.

Analysts Set New Price Targets

Separately, Jefferies Financial Group raised Raia Drogasil to a “buy” rating and set a $5.20 price objective on the stock in a research report on Sunday. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $5.20.

Raia Drogasil Stock Up 1.5%

The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.58 and a current ratio of 1.41. The company has a market cap of $5.70 billion and a price-to-earnings ratio of 28.90. The business has a 50-day simple moving average of $3.75 and a 200-day simple moving average of $3.85.

Raia Drogasil (OTCMKTS:RADLY) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, hitting analysts’ consensus estimates of $0.05. Raia Drogasil had a return on equity of 20.12% and a net margin of 2.99%. The business had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.32 billion. On average, equities analysts anticipate that Raia Drogasil S.A. will post 0.17 earnings per share for the current fiscal year.

About Raia Drogasil

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.